Aberrant Cell Signalling In Breast Cancer

  • Wakelam, Mike (Principal Investigator)

Project Details

Short titleAberrant Cell Signalling In Breast Cancer
StatusFinished
Effective start/end date1/10/9631/12/99

Funding

  • GlaxoSmithKline